Asia's ascent—global trends in biomedical R&D expenditures
New England Journal of Medicine, 2014•Mass Medical Soc
In recent years, industry has reduced its investment in US biomedical research and
development by billions of dollars, while increasing investment in Asia–Oceania. Thus,
boosting US government funding alone may be inadequate for retaining long-term R&D
leadership.
development by billions of dollars, while increasing investment in Asia–Oceania. Thus,
boosting US government funding alone may be inadequate for retaining long-term R&D
leadership.
In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.
The New England Journal Of Medicine